Penumbra Sale To Boston Scientific Recasts Growth Story For Investors
Penumbra (NYSE:PEN) is set to be acquired by Boston Scientific in a US$14.5b deal, following the release of strong quarterly...
Penumbra (NYSE:PEN) is set to be acquired by Boston Scientific in a US$14.5b deal, following the release of strong quarterly...
Content in second paragraph updated on 11/10/25. DALLAS, Nov. 10, 2025 — Despite major advances in care, nearly half of U.S....
DALLAS, Nov. 18, 2024 – While major advances are being made in prevention of cardiovascular disease and stroke, which affects...